Literature DB >> 35821453

Differences in aphasia syndromes between progressive supranuclear palsy-Richardson's syndrome, behavioral variant frontotemporal dementia and Alzheimer's dementia.

Lucia Ransmayr1,2, Alexandra Fuchs3,4, Sibylle Ransmayr-Tepser2, Romana Kommenda3,4, Mariella Kögl5, Petra Schwingenschuh5, Franz Fellner6,4, Michael Guger7,4, Christian Eggers2,4, Robert Darkow1, Stephanie Mangesius8, Gerhard Ransmayr9,10.   

Abstract

Language impairments, hallmarks of speech/language variant progressive supranuclear palsy, also occur in Richardson's syndrome (PSP-RS). Impaired communication may interfere with daily activities. Therefore, assessment of language functions is crucial. It is uncertain whether the Aachen Aphasia Test (AAT) is practicable in PSP-RS, behavioral variant frontotemporal dementia (bvFTD) and Alzheimer's dementia (AD) and language deficits differ in these disorders. 28 PSP-RS, 24 AD, and 24 bvFTD patients were investigated using the AAT and the CERAD-Plus battery. 16-25% of all patients failed in AAT subtests for various reasons. The AAT syndrome algorithm diagnosed amnestic aphasia in 5 (23%) PSP-RS, 7 (36%) bvFTD and 6 (30%) AD patients, Broca aphasia in 1 PSP-RS and 1 bvFTD patient, Wernicke aphasia in 1 bvFTD and 3 (15%) AD patients. However, aphasic symptoms resembled non-fluent primary progressive aphasia in 14 PSP-RS patients. In up to 46% of PSP-RS patients, 61% of bvFTD and 64% of AD patients significant impairments were found in the AAT subtests spontaneous speech, written language, naming, language repetition, language comprehension and the Token subtest. The CERAD-Plus subtest semantic fluency revealed significant impairment in 81% of PSP-RS, 61% of bvFTD, 44% of AD patients, the phonemic fluency subtest in 31, 40 and 31%, respectively. In contrast to bvFTD and AD, severity of language impairment did not correlate with cognitive decline in PSP-RS. In summary, the patterns of aphasia differ between the diagnoses. Local frontal language networks might be impaired in PSP-RS, whereas in AD and bvFTD, more widespread neuropathology might underly language impairment.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.

Entities:  

Keywords:  Alzheimer’s dementia; Behavioral variant frontotemporal dementia; Cognitive impairment; Non-fluent agrammatic primary progressive aphasia; Progressive supranuclear palsy

Mesh:

Year:  2022        PMID: 35821453     DOI: 10.1007/s00702-022-02524-2

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.850


  34 in total

1.  Classification of primary progressive aphasia and its variants.

Authors:  M L Gorno-Tempini; A E Hillis; S Weintraub; A Kertesz; M Mendez; S F Cappa; J M Ogar; J D Rohrer; S Black; B F Boeve; F Manes; N F Dronkers; R Vandenberghe; K Rascovsky; K Patterson; B L Miller; D S Knopman; J R Hodges; M M Mesulam; M Grossman
Journal:  Neurology       Date:  2011-02-16       Impact factor: 9.910

2.  The language profile of progressive supranuclear palsy.

Authors:  Eleonora Catricalà; Veronica Boschi; Sofia Cuoco; Francesco Galiano; Marina Picillo; Elena Gobbi; Antonio Miozzo; Cristiano Chesi; Valentina Esposito; Gabriella Santangelo; Maria Teresa Pellecchia; Virginia M Borsa; Paolo Barone; Peter Garrard; Sandro Iannaccone; Stefano F Cappa
Journal:  Cortex       Date:  2019-02-22       Impact factor: 4.027

3.  Slowing of cognitive processing in progressive supranuclear palsy. A comparison with Parkinson's disease.

Authors:  B Dubois; B Pillon; F Legault; Y Agid; F Lhermitte
Journal:  Arch Neurol       Date:  1988-11

4.  Aphasia in Progressive Supranuclear Palsy: As Severe as Progressive Non-Fluent Aphasia.

Authors:  James R Burrell; Kirrie J Ballard; Glenda M Halliday; John R Hodges
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

5.  Progressive nonfluent aphasia and subsequent aphasic dementia associated with atypical progressive supranuclear palsy pathology.

Authors:  B Boeve; D Dickson; J Duffy; J Bartleson; M Trenerry; R Petersen
Journal:  Eur Neurol       Date:  2003       Impact factor: 1.710

6.  Aphasia in dementia of the Alzheimer type.

Authors:  J L Cummings; F Benson; M A Hill; S Read
Journal:  Neurology       Date:  1985-03       Impact factor: 9.910

Review 7.  Summary of evidence-based guideline: periprocedural management of antithrombotic medications in patients with ischemic cerebrovascular disease: report of the Guideline Development Subcommittee of the American Academy of Neurology.

Authors:  Melissa J Armstrong; Gary Gronseth; David C Anderson; José Biller; Brett Cucchiara; Rima Dafer; Larry B Goldstein; Michael Schneck; Steven R Messé
Journal:  Neurology       Date:  2013-05-28       Impact factor: 9.910

8.  A longitudinal study of language decline in Alzheimer's disease and frontotemporal dementia.

Authors:  Mervin Blair; Cecile A Marczinski; Nicole Davis-Faroque; Andrew Kertesz
Journal:  J Int Neuropsychol Soc       Date:  2007-03       Impact factor: 2.892

9.  The clinico-metabolic correlates of language impairment in corticobasal syndrome and progressive supranuclear palsy.

Authors:  Alessandra Dodich; Chiara Cerami; Emanuela Inguscio; Sandro Iannaccone; Giuseppe Magnani; Alessandra Marcone; Priscilla Guglielmo; Giovanna Vanoli; Stefano F Cappa; Daniela Perani
Journal:  Neuroimage Clin       Date:  2019-10-21       Impact factor: 4.881

10.  Caregiver burden in patients with behavioural variant frontotemporal dementia and non-fluent variant and semantic variant primary progressive aphasia.

Authors:  Michael Guger; Stefan Raschbacher; Lukas Kellermair; Milan R Vosko; Christian Eggers; Thomas Forstner; Karin Leitner; Alexandra Fuchs; Franz Fellner; Gerhard Ransmayr
Journal:  J Neural Transm (Vienna)       Date:  2021-07-19       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.